Bringing purpose to life sciences through transformation and innovation

Bringing the spotlight to affordable therapy

Life sciences companies are facing the pressure of patent cliffs, regulatory pressures, and supply chain challenges. TheCOVID-19 pandemic brought into focus how industries can pool resources and expertise to fast-track personal protective equipment (PPE), ventilators, test kits, and vaccines.

• For life sciences organizations, the mandate is to accelerate safe, affordable therapies without compromising patient safety
• Life sciences companies pooled resources and expertise to fast-track PPE, ventilators, test kits, and vaccines in response to adverse events
• The cost to bring a drug to market now averages between $1 billion and $2 billion and can still take years. Patent cliffs as the patents expire also put pressure on revenue streams
• Changes in the demand for nonessential therapies have disrupted the supply chains of pharma and medtech companies

Genpact: Enabling healthcare transformation

Genpact enables its life sciences clients to help patients live longer, happier, more productive lives. We aim to improve the patient experience and enhance the flow of products and information.

The focus is on investment across the ecosystem, accelerating client efforts to deliver innovative therapies safely and at a fair price.

Here are some highlights that set Genpact apart from its competition:

• 700+ clients, one-fourth of which are Global Fortune 500 companies
• 70+ delivery centers in 30 countries
• 100,000+ employees

We enable innovation and collaboration for safe and affordable therapies

Drive compliance across functions for better decision-making

Genpact enables life sciences companies to leverage secure cloud-based applications across finance, regulatory affairs, procurement, and supply chain functions. This helps the companies standardize their process and improve visibility into their operations.

Unburdening regulatory affairs teams for better productivity

Genpact uses a variety of tools to process and standardize at scale and speed. Our technology partnership with leading companies allows Genpact to update compliance to meet regulatory submission standards.

Improved demand predictability and supply chain efficiency to maintain drug and device availability

Genpact can bring stability, visibility, and transparency to supply chain via process optimization, AI, advanced analytics, and managed services. Our master data management(MDM) capabilities enable data compliance and drug and device tracking and tracing.

Digital therapeutics for better insights and patient and healthcare providers experiences

Rightpoint, a Genpact company, helps monitor and manage patients to provide the necessary support and changes in treatment plans. Further, they can leverage tools like social media listening, hot spot analysis, GeoAI, digital health, and digital therapeutics for medical use.

With Genpact, clients can reap the benefits of:

• Compliance across functions
• Increased productivity of regulatory affairs teams
• Stability, visibility, and transparency in supply chain